Colloidal gold rapid Test - product market direction analysis!

Colloidal gold rapid diagnostic reagent is a biomedical reagent commonly used in clinical diagnosis and detection. Based on the principle of colloidal gold technology, it reacts with specific target molecules in patient samples to produce visible color changes, thereby quickly and accurately diagnosing diseases or detecting indicators.

At present, the colloidal gold rapid diagnostic reagent market is developing rapidly and has broad prospects. This is mainly driven by the following factors:

1. Advances in medical technology

Colloidal gold rapid diagnostic reagents have the characteristics of easy operation, quick results and high sensitivity, and can provide accurate diagnostic information in a short time. With the continuous advancement of medical technology, people's demand for rapid and accurate diagnosis is increasing, and colloidal gold rapid diagnostic reagents can meet this demand.

2. The need for disease prevention and early screening

Colloidal gold rapid diagnostic reagents are widely used in the diagnosis and screening of various pathological conditions such as infectious diseases and tumors. Especially in the prevention and control of infectious diseases, the use of colloidal gold rapid diagnostic reagents can help quickly detect whether patients are infected with pathogens, and help to take early isolation and treatment measures to effectively control the spread of diseases.

3. Optimization of medical resource allocation

Colloidal gold rapid diagnostic reagents can perform rapid diagnosis in primary medical institutions, reduce the time and economic cost of patients going to large hospitals for complex testing, improve the utilization efficiency of medical resources, and provide strong technical support for primary medical workers.

4. Increased demand from emerging markets

With the global aging trend and population growth, the incidence and burden of diseases are gradually increasing. Therefore, the demand for rapid and accurate diagnosis and detection is also increasing, which will further promote the development of the colloidal gold rapid diagnostic reagent market.

Note that there are two sections:

1. Products for human use

The earliest commercialization of colloidal gold technology was in early pregnancy test strips. At present, several large colloidal gold test strip production companies in China, such as Beijing Blue Cross, Hangzhou Aikang, Beijing Wanhua Pullman, and Shantou David, all have early pregnancy test strips. Products, especially Blue Cross, accounted for more than 80% of the domestic market. Such products mainly include HCG, LH, FSH, Tang’s, etc. Domestic HCG has been recognized by customers, and the sales volume has always been very good. However, due to the mature technology and many manufacturers participating in the competition, it has come to rely on saving costs and reducing consumption. Large amount of profit stage. The intensity of competition far exceeds the growth rate of the market.

A large amount of profits generated in this market are divided among several large manufacturers. At the same time, the low-price strategy has formed a strong squeeze on small manufacturers, making the market share tend to be concentrated. In recent years, the capacity of the market will further expand as test paper enters households. Traditional craft test paper will continue to provide profits for the company, but the profit situation has declined significantly. The products combined with electronic testing, multi-item products, and semi-quantitative products that are currently sold abroad will become new profit growth points in this field.

Drugs and drug residues are currently another hot spot. As China's social problems further deepen, drug abuse control will become an important task for government security agencies. At present, the customer groups of this product are mainly social security agencies such as public security organs, drug rehabilitation centers, and security bureaus, so the sales method generally adopts the way of upper-level relations. The monopoly phenomenon that led to the use of different brands of test strips by different local governments.

The manufacturing process of drugs is constantly innovating, and the process of test strips has also undergone great changes. The original all-in-one products, urine cups and other products can no longer simply copy and occupy the market. At present, K powder, G The detection of powder adopts a more convenient detection method. If there is strong government support, drugs will become the biggest long-term profit support point for companies in this industry.

A full set of colloidal gold detection technology platform transfer, limited time and price!

On the high-end R&D platform, the research on drug residues in the human body is ongoing. The difference between it and ordinary drug testing is that the test object has been transferred from illegal drugs to legal samples. Many foreign drug manufacturing institutions have this consideration. The medicines they sell are directly related, so that the situation of the medicines can be effectively and easily monitored, but the profit prospect of the products is still unpredictable.

Infectious disease testing, including HIV, HCV, HBV, HBsAg, etc. As far as market demand is concerned, the space is very large, but the technology for mass production seems to be immature, and the output of a single batch is still very small. There are many problems when zooming in. At the same time, the detection of serum and whole blood has limited the scope of customers to medical institutions (it takes a lot of energy and money to open up this market). The market acceptance is good and it is expected to create certain profits for the company.

The direction of tumor marker technology, this direction is still very immature in general, and the investment in research and development will be further increased, and it may be difficult to make profits in a short period of time. In terms of markers, there are myocardial protein products, which are doing well abroad, but there are no products of good quality in China.

I don't know much about chlamydia products, so I won't say more. There are not many domestic sales, and there are not many foreign ones.

2. Agricultural, animal and food safety products

The clenbuterol incident must be still fresh in everyone's memory. The clenbuterol test strips brought the first pot of gold to the pioneers of many animal husbandry test strips. Dalian Prekang has done a better job in this field, and WHPM is also developing food safety testing. At present, there are multiple directions such as avian influenza, livestock epidemics, pesticide residues, and food and drug residues. Not many have really reached industrialization, the market is relatively blank, and the profit prospect is very good.

My personal suggestion is to act immediately after seeing the direction. If you wait until a good market is formed before developing and producing, it will lose its meaning. This article expresses my personal opinion that the market will always come first.